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SirtuinsAging is associated with a loss in muscle known as sarcopenia that is partially attributed to apoptosis. In aging
rodents, caloric restriction (CR) increases health and longevity by improving mitochondrial function and the
polyphenol resveratrol (RSV) has been reported to have similar beneﬁts. In the present study, we investigated
the potential efﬁcacy of using short-term (6 weeks) CR (20%), RSV (50 mg/kg/day), or combined CR + RSV
(20% CR and 50 mg/kg/day RSV), initiated at late-life (27 months) to protect muscle against sarcopenia by
altering mitochondrial function, biogenesis, content, and apoptotic signaling in both glycolytic white and oxida-
tive red gastrocnemius muscle (WG and RG, respectively) of male Fischer 344 × Brown Norway rats. CR but not
RSV attenuated the age-associated loss of muscle mass in both mixed gastrocnemius and soleus muscle, while
combined treatment (CR + RSV) paradigms showed a protective effect in the soleus and plantaris muscle
(P b 0.05). Sirt1 protein content was increased by 2.6-fold (P b 0.05) in WG but not RG muscle with RSV
treatment, while CR or CR + RSV had no effect. PGC-1α levels were higher (2-fold) in the WG from
CR-treated animals (P b 0.05) when compared to ad-libitum (AL) animals but no differences were observed
in the RG with any treatment. Levels of the anti-apoptotic protein Bcl-2 were signiﬁcantly higher (1.6-fold) in
the WG muscle of RSV and CR + RSV groups compared to AL (P b 0.05) but tended to occur coincident with
elevations in the pro-apoptotic protein Bax so that the apoptotic susceptibility as indicated by the Bax to
Bcl-2 ratio was unchanged. There were no alterations in DNA fragmentation with any treatment in muscle
from older animals. Additionally, mitochondrial respiration measured in permeabilized muscle ﬁbers was
unchanged in any treatment group and this paralleled the lack of change in cytochrome c oxidase (COX)
activity. These data suggest that short-termmoderate CR, RSV, or CR + RSV tended to modestly alter key mito-
chondrial regulatory and apoptotic signaling pathways in glycolytic muscle and this might contribute to the
moderate protective effects against aging-induced muscle loss observed in this study.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Aging is a complex physiological process that is due, in part, to the
accumulation of damage at the molecular, cellular, and organ levels
that eventually manifests as impairments in whole body function.
One of the hallmark features of aging in mammals is the progressive
loss of muscle mass and strength known as sarcopenia (Rosenberg,
1997). This condition is characterized by a progressive loss of
skeletal muscle and shown to be partially attributed to changes inGeriatric Research, UF Institute
USA. Tel.: +1 352 294 5517;
rights reserved.mitochondrial ultrastructure and decrements in organelle function,
biogenesis, and content (Calvani et al., 2013). While the speciﬁc mo-
lecular underpinnings of these changes continue to be enigmatic,
much of the research has focused on the role of life-long exposure
to oxidative stress and the steady accretion of intracellular damage
due to the reactive oxygen species (ROS) produced largely by mito-
chondria (Siu et al., 2008). Chronic lifetime exposure of muscle to
elevated levels of ROS has been postulated to result in a steady accu-
mulation of damage to macromolecules such as DNA, proteins and
lipids (Harman, 2003). This can subsequently lead to reduced bioen-
ergetics and the activation of key mitochondrially-mediated apopto-
sis signaling pathways resulting in myonuclear loss. Since skeletal
muscle is uniquely multi-nucleated, a reduced myonuclear number
resulting from apoptosis reduces the myonuclear domain (nuclear
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notype observed in aging (Chabi et al., 2008; Dirks and Leeuwenburgh,
2002; Whitman et al., 2005). Interestingly, age-related muscle abnor-
malities and susceptibility to ﬁber loss appear to occur in a ﬁber-type
speciﬁc manner with fast-twitch glycolytic ﬁbers being more affected
than slow-twitch oxidative ﬁbers (Aspnes et al., 1997; Bua et al.,
2002; McKenzie et al., 2002; Phillips and Leeuwenburgh, 2005; Pistilli
et al., 2006; Rice and Blough, 2006).
Mitochondrial content in skeletal muscle is dynamic and unique
since it can be altered in response to a wide variety of physiological
stimuli which includes but is not limited to exercise, chronic contractile
activity, chronic muscle disuse, and caloric restriction (Hood, 2001). To
date, life-long caloric restriction (consumption of 20–40% fewer calo-
ries) remains the only recognized intervention capable of delaying
age-related diseases and improving health and longevity in numerous
species ranging from yeast to rodents (reviewed in Speakman
and Mitchell, 2011). In muscle, caloric restriction delays the age-
associated loss of muscle ﬁbers, in part, by improving mitochondrial
function, preventing the induction of apoptotic signaling pathways,
and reducing the release of pro-apoptotic factors from the mitochon-
dria that lead to myonuclear DNA fragmentation (Aspnes et al., 1997;
Dirks and Leeuwenburgh, 2004; Lee et al., 1998). At a molecular level,
caloric restriction exerts its beneﬁcial effects by evoking a cellular
state of energy deprivation which activates key signaling molecules
such as the NAD+-dependent deacetylase sirtuin 1 (Sirt1), one of the
seven mammalian sirtuin homologs of the yeast Sir2 gene (Cohen et
al., 2004; Frye, 1999). In fact, proof-of-concept genetic experiments
have shown that Sirt1-overexpressing mice display similar beneﬁcial
phenotypes as caloric restricted mice (Bordone et al., 2007), while
knockout animals have a shorter lifespan compared to their wild-type
counterparts (Guarente and Picard, 2005; Koubova and Guarente,
2003; McBurney et al., 2003). At a biochemical level, Sirt1 functions as
a deacetylase and one of its prominent targets is the mitochondrial reg-
ulator peroxisome proliferator-activated receptor gamma coactivator-1
alpha (PGC-1α) (Rodgers et al., 2005). Upregulation of PGC-1α in
muscle activates a number of genes involved in substrate metabolism
leading to elevated mitochondrial biogenesis, improved mitochondrial
function, as well as a ﬁber type transition towards muscle with a more
oxidative metabolic proﬁle (Lin et al., 2002; Wu et al., 1999). Moreover,
increased PGC-1α levels attenuate the muscle mass loss observed in
aging animals (Wenz et al., 2009). The effects of PGC-1α on muscle mi-
tochondrial biogenesis are also largely mediated by 5′ AMP-activated
protein kinase (AMPK), a key metabolic sensor that regulates PGC-1α
by increasing its expression levels, as well as directly phosphorylating
the protein (Irrcher et al., 2008; Jager et al., 2007; Suwa et al., 2003).
While a number of observations have linked these mitochondrial me-
tabolism and biogenesis regulatory proteins to the caloric restriction-
mediated protection observed in aging muscle, the molecular details of
their involvement remain elusive.
Recently, resveratrol (3, 5, 4′-trihydroxystilbene), a natural poly-
phenol found in grape skins and red wine has gained much attention
for its ability to induce Sirt1 activity and has been purported to exert
anti-aging effects on various organisms (Howitz et al., 2003). Resver-
atrol is marketed as, and termed a “caloric restriction mimetic” since
it can extend lifespan in lower organisms including yeast, drosophila,
and small vertebrates and seems to operate via the same molecular
machinery as caloric restriction (Howitz et al., 2003; Valenzano et
al., 2006; Wood et al., 2004). The effects of resveratrol appear to be
mediated through an AMPK-Sirt1-PGC-1α pathway but the mecha-
nisms of this regulation are currently not well understood (Baur et
al., 2006; Canto et al., 2009; Dasgupta and Milbrandt, 2007; Lagouge
et al., 2006; Price et al., 2012; Um et al., 2010). Nonetheless, the ben-
eﬁts of resveratrol are not limited only to life extension properties
since it has also been shown to improve the health decrements
associated with diet-induced obesity. Speciﬁcally, in mice fed a high
fat diet, resveratrol protected against aging diet-induced obesity,increased overall mitochondrial content, improved muscle strength
and enhanced aerobic capacity, while importantly also extending
lifespan in these rodents (Baur et al., 2006; Lagouge et al., 2006).
Favorable metabolic improvements following resveratrol treatment
have also been reported in humans (Brasnyo et al., 2011; Crandall
et al., 2012; Timmers et al., 2011). Thus, resveratrol treatment
appears to improve general health measures in both humans and
animals and this seems to be partially mediated via mitochondrial
adaptations. Interestingly, the health beneﬁts derived from resvera-
trol treatment can be realized with short-term supplementation as
opposed to the life-long commitment of caloric restriction which
has signiﬁcant clinical implications from an intervention standpoint.
It is currently unclear whether short-term and/or late-life implemen-
tation of resveratrol supplementation can provide similar mitochon-
drial adaptations to improve overall health and suppress muscle
wasting conditions such as sarcopenia. Some studies report improved
mitochondrial protein expression proﬁle, skeletal muscle function,
and an attenuation of muscle mass loss during muscle disuse, cachex-
ia, and aging (Jackson et al., 2010; Wyke et al., 2004), while other
studies fail to show similar beneﬁts. However, these contrasting
results seem to be mainly attributed to differences in treatment
dose and time (Jackson et al., 2011). Despite these inconsistent
ﬁndings, the general consensus in the ﬁeld is that due to its ability
to modulate mitochondrial gene expression and its potential antioxi-
dant properties, resveratrol may attenuate the oxidative stress
burden imposed by aging to potentially protect and/or suppress the
onset of sarcopenia (Jackson et al., 2010, 2011; Murase et al., 2009;
Ryan et al., 2010). To date however, it is unclear whether the beneﬁts
of caloric restriction and resveratrol treatment occur via similar
pathways, or whether there may be some independence between the
intracellular pathways that activate mitochondrial biogenesis, improve
mitochondrial function and/or suppress mitochondrially-mediated
apoptotic signaling pathways. Furthermore, given the differential
sarcopenic effect of aging onmuscleﬁber-types (preferentially affecting
fast/glycolytic versus slow/oxidative), it is currently unknown whether
these treatment paradigms induce ﬁber-type speciﬁc responses.
The purpose of the current study was to evaluate the efﬁcacy of
moderate short-term caloric restriction, resveratrol, or combined
caloric restriction/resveratrol treatments to modulate mitochondrial
function, biogenesis, and apoptotic susceptibility proteins to poten-
tially delay sarcopenia in late-life aged animals. This is the ﬁrst
study to assess whether these short-term treatment paradigms
implemented in late-life could provide beneﬁcial mitochondrial and
muscle adaptations. We hypothesized that 6 weeks of caloric restric-
tion (20%) or resveratrol (50 mg/kg/day) supplementation would
independently improve mitochondrial function and content, and re-
duce apoptotic susceptibility, and that combined treatment would
exert an additive or potentially a synergistic protective effect in
aging muscle. Additionally, we hypothesized that the regulation of
these pathways would differ between the fast-twitch and slow-
twitch gastrocnemius muscle.
2. Materials and methods
2.1. Animals
Muscle tissue from a total of thirty-one 27-month-old male
Fischer 344 × Brown Norway Hybrid rats purchased from the National
Institute on Aging was used in this study. These animals were part of a
larger study (n = 64). All experimental procedures were approved by
the Institutional Animal Care and Use Committee at the University of
Florida (Study#:200902992) and performed in accordance with the
National Institutes of Health guidelines for the care and use of laborato-
ry animals. The animals were acclimatized for 4 weeks before the start
of intervention and housed in separate cages in a temperature
(18–22 °C) and light-controlled environment with a 12-hour light/
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treatment groups: ad-libitum (AL), caloric restricted (CR) (20% reduced
AL; 6 weeks), resveratrol (RSV) (50 mg/kg/day; 6 weeks), CR + RSV
(20% CR and 50 mg/kg/day RSV for 6 weeks). All animals received a
daily diet of food pellets (Custom Animal Diets, Bangor, PA). The aver-
age food intake of the AL group was determined and used to calculate
the 20% reduction in caloric intake for the CR group. Animals in the RSV
treated groups received a daily dose of one bacon ﬂavored RSV fortiﬁed
tablet (50 mg/kg/body weight), mixed in with their normal food
pellets (Sigma Chemical Co., St. Louis, MO). The bioavailability of res-
veratrol and its conversion into dihydroresveratrol was conﬁrmed by
measuring resveratrol levels in plasma. At the end of the 6 weeks of
treatment, animals were sacriﬁced, tibialis anterior, and red and
white portions of the gastrocnemius muscle were separated, weighed,
frozen in liquid nitrogen, and stored at −80 °C until further analysis.
2.2. Preparation of permeabilized muscle ﬁbers
Portions of the tibialis anterior muscle were excised and immedi-
ately processed for permeabilized ﬁber respiration measurements as
previously described (Joseph et al., 2012). Brieﬂy, muscle from the
tibialis anterior (~20–25 mg) was placed in ice-cold Buffer X containing
60 mM K-MES, 35 mM KCl, 7.23 mM K2EGTA, 2.77 CaK2EGTA, 20 mM
imidazole, 0.5 mM DTT, 20 mM taurine, 5.7 mM ATP, 15 mM PCr, and
6.56 mM MgCl2·6 H2O (pH 7.1, 295 mosmol/kgH2O) and connective
tissue removed. Muscle sections were cut into small bundles (~8–
10 mg) and gently separated into single ﬁbers. Myoﬁbers were perme-
abilized in Buffer Xwith saponin (50 μg/ml) and incubated on a rotator
for 30 min at 4 °C. Permeabilized ﬁbers were washed in ice-cold Buffer
Z containing 110 mM K-MES, 35 mM KCl, 1 mM EGTA, 5 mM K2HPO4,
and 3 mMMgCl2·6H2O, 0.05 mM pyruvate, and 0.02 mMmalate with
0.5 mg/ml BSA (pH 7.1, 295 mosmol/kgH2O) on a rotator at 4 °C for
45 min. Fiber bundles were subsequently washed in Buffer Z containing
5 mM pyrophosphate to deplete ﬁbers of endogenous nucleotides.
2.3. Mitochondrial respiration in permeabilized muscle ﬁbers
Respiration was measured using an Oroboros O2K Oxygraph
(Inssbruck, Austria) according to methods previously described
(Kuznetsov et al., 1998). The O2 ﬂux rate was measured following the
addition of a substrate and inhibitor protocol which consisted of
5 mM pyruvate and 2 mM malate, 2 mM ADP, 10 μM cytochrome c,
10 mM succinate, 2 μg/ml oligomycin and 0.5 μM carbonylcyanide
p-triﬂuoromethoxyphenylhydrazone. Respiratory control ratios (state
3/state 4) were used as an indicator of well-coupled mitochondria in
all groups measured (mean RCR = 5.07 ± 0.4).
2.4. Cytochrome c oxidase (COX) enzyme activity
Powdered tissues fromwhite gastrocnemius, red gastrocnemius, and
the tibialis anterior were diluted in a buffer (0.1 M KH2PO4 + 2 mM
EDTA, pH 7.2) and sonicated (3 × 5 s) on ice. Following a brief spin,
the supernatant was removed and enzyme activity determined by the
maximal oxidation rate of completely reduced cytochrome c, evaluated
as a change in absorbance at 550 nm using a multi-detectionmicroplate
reader (Synergy HT, Biotek Instruments, Winooski, VT) (Adhihetty et al.,
2009).
2.5. Western blotting
Frozen white and red gastrocnemius muscles were pulverized and
protein extracts made as previously described (Adhihetty et al.,
2009). Muscle extracts (50 μg/lane) were separated by 4–15%
SDS-PAGE and subsequently electroblotted to nitrocellulose mem-
branes. After transfer, membranes were blocked by incubating at
room temp in 5% skim milk in 1X TBST [Tris-buffered saline-Tween20:25 mM Tris HCl (pH 7.5), 1 mM NaCl, and 0.1% Tween 20] solu-
tion. Blots were then incubated overnight at 4 °C in blocking buffer
at a dilution of 1:3500 for AIF (Santa Cruz, sc-9416), 1:1000 for Bax
and Bcl-2 (Santa Cruz, sc-493 and sc-7382), 1:1500 for cytochrome
c (Santa Cruz sc-8385), 1:1500 for MnSOD (Santa Cruz, sc-30080),
PGC-1α (Calbiochem, 516557), phospho-AMPKα and total AMPKα
(Cell Signaling 2531 and 2532, respectively) and Sirt1 (Cell Signaling,
8469). After overnight incubation, blots were washed in TBST
(3 × 5 min), incubated at room temperature for 45 min with appro-
priate secondary antibody, and washed again in TBST (3 × 5 min).
Antibody binding was detected with the use of secondary antibodies
conjugated to horseradish peroxidase and an enhanced chemilumi-
nescence (ECL) detection kit (Santa Cruz Biotechnology, Santa Cruz,
CA). Films were scanned and images analyzed using the Kodak ID
Imaging Software. Target bands were normalized to the amount of
protein loaded in each lane, as determined by densitometric analysis
of the corresponding Ponceau S-stained (Marzetti et al., 2009a).
2.6. Cell death ELISA assay
DNA fragmentation in both white and red gastrocnemius muscle
samples was measured using the Cell Death ELISA DetectionPLUS kit
(Roche Diagnostics, Indianapolis, IN). This assay has commonly been
used to accurately assess apoptosis in skeletal muscle of both young
and old animals (Pistilli and Alway, 2008). Brieﬂy, tissue was homoge-
nized in lysis buffer followed by centrifugation at 200 g for 10 min to
obtain the cytosolic fraction. Subsequently, 20 μg of supernatant was
added into the wells of a streptavidin-coated plate and incubated
with 80 μl anti-histone-biotin and anti-DNAPOD for 2 h on a shaker
at room temperature. The wells were then washed and incubated
with the substrate, 2,2′-azino-di (3-ethylbenzthiazoline sulfate)
(ABTS) on a shaker for 10–20 min. Absorbance was measured at
405 nm with a multi-detection microplate reader (Synergy HT, Biotek
Instruments, Winooski, VT). Positive and negative controls were run
with each assay and values adjusted for background. The resulting
OD was recorded as the apoptotic index (OD405/mg protein).
2.7. Statistical analysis
One-way analysis of variance (ANOVA) was performed to deter-
mine whether there was a main effect of treatment followed by a
Tukey's post-hoc test to identify differences within groups. Statistical
differences were considered signiﬁcant if P b 0.05. Data are expressed
as means ± SE.
3. Results
3.1. Animal characteristics
Animals used in this study were a subset from a larger study and
therefore the descriptive animal characteristics in Table 1 represent a
summary of the total animals in the study (n = 64). Animal weights
were taken prior to and following 6 weeks of the dietary inter-
vention. Animals were given a daily resveratrol dose of 50 mg/kg/day
of body weight. This dose has been previously shown to be within the
range that induces changes in mitochondrial protein expression path-
ways with long-term treatment but well below the threshold that can
potentially lead to apoptosis (Jackson et al., 2011). Bodyweights indicat-
ed in Table 1 were taken prior to and following 6 weeks of intervention,
immediately before the animals were sacriﬁced. As expected, animal
weights at baseline were not different between groups, but caloric
restriction (CR), and caloric restriction with resveratrol (CR + RSV)
groups, had a signiﬁcantly lower body mass compared to ad-libitum
(AL)-fed animals (P b 0.05) at the end of the 6 weeks of treatment.
Also, following the intervention, animals in the CR and CR + RSV groups
had similar percent losses in bodyweight,while reduced compared to AL
Table 1
Descriptive characteristics of animals.
Characteristic AL CR RSV CR + RSV
Number of animals 23 9 8 24
BW (pre) (g) 567 ± 13.2 564.6 ± 16.3 559 ± 13.0 567.3 ± 17
BW (post) (g) 581 ± 8.0 529 ± 15.1* 565 ± 16.6 521 ± 7.1*#
%Δ BW (g) 1.2 ± 0.47 −6% ± 0.73*# 1.0 ± 1.18 −8% ± 1.56*#
Gastrocnemius muscle wet weight (g) 1.89 ± 0.03 1.95 ± 0.05 1.88 ± 0.06 1.77 ± 0.03*†
Gastrocnemius muscle wet weight/BW 3.30 ± 0.04 3.7 ± 0.16*#¶ 3.33 ± 0.09 3.40 ± 0.05
Soleus muscle wet weight (g) 0.17 ± 0.004 0.18 ± 0.003 0.17 ± 0.004 0.16 ± 0.003
Soleus muscle wet weight/BW 0.29 ± 0.007 0.32 ± 0.007* 0.30 ± 0.008 0.31 ± 0.004*
Plantaris muscle wet weight (g) 0.47 ± 0.02 0.43 ± 0.02 0.42 ± 0.02 0.47 ± 0.04
Plantaris muscle wet weight/BW 0.80 ± 0.02 0.82 ± 0.03 0.74 ± 0.04 0.90 ± 0.02*#
Food intake (g/day) 2.54 ± 0.03 2.07 ± 0.03* 2.60 ± 0.09† 1.97 ± 0.01*#
Animals were weighed prior to (pre) and following the 6-week intervention (post) and body weights (BW) represented in grams (g) and as percent changes (%Δ). Muscle weights
were taken immediately following excision and data represented as a ratio to body weight (mg/g). Animals were randomly assigned to 4 groups which included ad-libitum (AL,
regular chow), Caloric Restricted (CR; 20%), Resveratrol (RSV; 50 mg/kg/day), or combined Caloric Restricted and Resveratrol (CR + RSV; 20% CR and 50 mg/kg/day RSV). *Signif-
icantly different (P b 0.05) than AL animals. †Signiﬁcantly different (P b 0.05) than CR. #Signiﬁcantly different (P b 0.05) than RSV. ¶Signiﬁcantly different (P b 0.05) than
CR + RSV. All data are represented as mean ± SE.
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any treatment on gross muscle weights although a reduction in the gas-
trocnemiusmusclewas detected in the CR + RSV group compared to AL
and CR (P b 0.05). However, since body masses differ signiﬁcantly be-
tween groups, gross muscle weights were corrected for body weight to
obtain a more accurate depiction of changes. After normalizing muscle
weights by mean body weight, we found that both the gastrocnemius
and soleus muscle were higher (P b 0.05) with CR compared to AL
(Table 1). Additionally, CR + RSV treatment resulted in a protective
effect in the soleus, as well as the plantaris muscle (P b 0.05).
3.2. Mitochondrial function and enzyme activity
Mitochondrial function was measured by directly assessing
oxygen consumption in permeabilized muscle ﬁbers from the tibialis
anterior muscle (Table 2). Respiratory control ratios for all groups
were between the range of 3.5–5.1 indicating well coupled mitochon-
dria. Mitochondrial respiration rates were unchanged by any of the
interventions, even when corrected for COX activity (common mark-
er of mitochondrial content) in the same tissue (data not shown)
(Adhihetty et al., 2007). This was also substantiated, and consistent
with COX activity measured in white-gastrocnemius (WG) and red
gastrocnemius (RG) muscles (Table 2).
3.3. AMPK activation and sirtuin 1 (Sirt1) protein content
Activation of the upstreammetabolic sensor AMPK was not differ-
ent in any of the groups in the WG (Fig. 1A) or RG (Fig. 1C). However,
Sirt1 protein was 2.6-fold higher (P b 0.05) in RSV-treated WGTable 2
Mitochondrial respiration and enzyme activity.
Measurement AL CR RSV CR + RSV
Oxygen consumption (pmol/s/mg wet weight)
State 4 16.81 ± 0.29 15.78 ± 1.44 15.65 ± 1.25 15.79 ± 1.35
State 3 59.80 ± 5.32 64.33 ± 9.15 56.43 ± 8.09 68.57 ± 11.5
RCR 3.54 ± 0.25 4.65 ± 0.94 4.00 ± 0.96 5.07 ± 0.4
Cytochrome c oxidase activity (U/g)
White
Gastrocnemius
8.76 ± 0.74 9.08 ± 1.47 9.67 ± 1.27 8.60 ± 0.31
Red
Gastrocnemius
24.0 ± 1.34 21.2 ± 1.84 25.0 ± 2.97 20.5 ± 1.84
Oxygen consumption was performed in permeabilized muscle ﬁbers from the tibialias
anterior. Rate of mitochondrial oxygen consumption in the presence (state 3) or
absence (state 4) of ADP. Respiratory control ratio (RCR). Values are means ± SEM
of 4–8 mice. There were no statistical differences between groups (P b 0.05).muscle when compared to muscle from AL-fed animals (Fig. 1B).
There were no detectable differences in Sirt1 protein content in RG
muscle (Fig. 1D). Additionally, activation of the mammalian target
of rapamycin (mTOR) kinase, a downstream target of AMPK was not
different between any groups (data not shown).
3.4. Mitochondrial biogenesis
Protein levels of peroxisome proliferator-activated receptor
gamma coactivator-1 alpha (PGC-1α) were 2-fold higher in the WG
following CR treatment when compared to AL (P b 0.05; Fig. 2A),
and reduced in the CR + RSV group when compared to both CR and
RSV groups (P b 0.05; Fig. 2A). In contrast, no changes were detected
in PGC-1α protein in the RG muscle (Fig. 2C). Cytochrome c protein
content was not affected by any treatments in the WG (Fig. 2B) or
RG (Fig. 2D) muscles.
3.5. Apoptosis regulatory proteins
To investigate whether apoptotic potential is modulated in aged
muscle following supplementation, several apoptosis regulatory pro-
teins were measured. Apoptosis Inducing Factor (AIF) protein content
was markedly elevated in RSV treated RG muscle (1.5-fold) (P b 0.05;
Fig. 3C) compared to AL-fed animals but not altered with CR or
CR + RSV. No differences were detected in the levels of this protein
in WG muscle (Fig. 3A). The antioxidant enzyme manganese superox-
ide dismutase (MnSOD) was 1.7-fold higher in the WG muscle of
CR-treated animals (P b 0.05; Fig. 3B) but was not statistically different
in the RG (Fig. 3D). Next we wanted to measure levels of the
pro-apoptotic protein Bax and the anti-apoptotic protein Bcl-2 which
are crucial factors in the susceptibility to apoptosis. RSV increased the
abundance of Bax protein in WG compared to muscle from AL-fed an-
imals (P b 0.05; Fig. 4A), an effect that was attenuated by combined
CR + RSV treatment (P b 0.05). Levels of the anti-apoptotic protein
Bcl-2 were also elevated in WG muscle of RSV treated animals
(P b 0.05), as well as in animals treated with combined CR + RSV
(P b 0.05) compared to AL-fed animals (Fig. 4C). In contrast to WG
muscle, there were no signiﬁcant changes in the levels of these apopto-
sis regulators in RG (Fig. 4B and D). The Bax/Bcl-2 ratio, commonly
used as an indicator of apoptotic susceptibility was not different
between any of the groups in either muscle.
3.6. Efﬁcacy of CR and RSV supplementation on cell death in aging muscle
To determinewhether cell death was affected by the treatment reg-
imens, we used a cell death ELISA to measure DNA fragmentation in
both WG and RG (indicated as apoptotic index). CR, RSV or combined
Fig. 1. AMPK activation and Sirtuin 1 (Sirt1) protein content. AMPK activation was measured in white gastrocnemius (WG; A) and red gastrocnemius (RG; C) muscle in 27 month
old AL = ad-libitum fed (n = 11), CR = caloric restricted (n = 4), RSV = resveratrol (n = 4), and CR + RSV = caloric restricted + resveratrol (n = 12). Kinase activation sta-
tus was determined as the ratio of the phosphorylated form (p-AMPKα) of the protein compared to the total protein (AMPKα) content for each sample. Sirt1 protein in WG (B) and
RG (D) muscle. Representative protein blots are shown along with the corresponding Ponceau S-stained membrane used to correct for loading. A graphical summary of the data is
shown below (n = 4–11). Signiﬁcance was set at P b 0.05 and all data are represented as mean ± SE. Data are expressed as arbitrary units (AU). *P b 0.05 vs. AL.
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either the WG (Fig. 5A) or RG muscles (Fig. 5B) supporting the lack
of change observed in the Bax/Bcl-2 ratio.
4. Discussion
Oxidative stress beyond a certain threshold is a well-established
inducer of cellular dysfunction since this can lead to the dysregulationof a number of key cellular pathways including cell growth, prolifer-
ation and survival (Migliore and Coppede, 2002; Ryter et al., 2007).
Aging muscle is particularly susceptible to oxidative stress due to
age-induced reductions in overall antioxidant and repair pathways
which are responsible for managing and/or neutralizing the levels of
stress imposed by elevated oxidants (Pansarasa et al., 1999; Proctor
et al., 1995). This elevation in oxidative stress in muscle throughout
life can cause cumulative detrimental effects which may eventually
Fig. 2. PGC-1α and cytochrome c protein content. PGC-1α protein was measured in white gastrocnemius (WG; A) and red gastrocnemius (RG; C) muscles and cytochrome c protein
in WG (B) and RG (D) in 27 month old AL = ad-libitum, CR = caloric restricted, RSV = resveratrol, and CR + RSV = caloric restricted + resveratrol. Representative Western
blots and corresponding Ponceau S-stained membranes, along with a graphical summary of the data is shown (n = 4–11). Signiﬁcance was set at P b 0.05 and all data are repre-
sented as mean ± SE. Data are expressed as arbitrary units (AU). *P b 0.05 vs. AL; †P b 0.05 vs. CR group and RSV group.
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bioenergetics, as well as higher apoptotic potential culminating in
myonuclear cell death and ultimately muscle loss (Calvani et al.,
2013; Harman, 2003). Thus, disturbances in the balance between
oxidants and reductants are believed to be a signiﬁcant contributor
towards sarcopenia. The present study is the ﬁrst to determine
whether short-term interventions of moderate caloric restriction,
resveratrol, or combined caloric restriction and resveratrol treatment
could improve keymitochondrial and apoptotic pathways to suppress
the signaling events that typically lead to muscle loss in late-life
aging.
Previous studies report that long-term (initiated at late middle
age) caloric restriction of greater than 40% preserves ﬁber numberand ﬁber type composition in rodents (Aspnes et al., 1997; Lee et
al., 1998; Phillips and Leeuwenburgh, 2005). However, this strict die-
tary restriction is not tolerated well by older animals and is certainly
not feasible and/or easily translatable to humans (Dirks and
Leeuwenburgh, 2006). Thus, we elected to use a much more tolerable
20% dietary restriction to be a more moderate and applicable treat-
ment regimen that could potentially be implemented in humans, in
particular if used in conjunction with resveratrol treatment. Although
we did not anticipate large changes in muscle mass given the brevity
of the treatment time and the moderate dose, we did observe what
appeared to be a modest protective effect in both the slow-twitch so-
leus and mixed gastrocnemius muscle following caloric restriction
when muscle mass was normalized for body weight. Additionally,
Fig. 3. Apoptosis Inducing Factor (AIF) and Manganese Superoxide Dismutase (MnSOD) protein content. AIF protein was measured via immunoblotting in white gastrocnemius
(WG; A) and red gastrocnemius (RG; C) muscles and MnSOD protein in WG (B) and RG (D). AL = ad libitum, CR = caloric restricted, RSV = resveratrol, and CR + RSV = caloric
restricted + resveratrol. Representative blots are shown above with the corresponding Ponceau S-stained membrane below. A summary of repeated experiments is graphically
illustrated (n = 4–11). Signiﬁcance was set at P b 0.05 and all data are represented as mean ± SE. Data are expressed as arbitrary units (AU). *P b 0.05 vs. AL.
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positively affected muscle mass in the soleus and plantaris muscle
but not the mixed gastrocnemius muscle. The lack of change observed
in the mixed gastrocnemius muscle is due to the loss of absolute mus-
cle mass with the combination of treatments. At present, we are unsure
of whether ﬁber mass loss is more detectable due to the larger overall
size of the muscle compared to smaller muscles such as the soleus and/
or plantaris or whether this represents a physiologically relevant ﬁnd-
ing unique to the mixed gastrocnemius muscle. However, it is impor-
tant to note that muscle weight measurements can be affected by a
number of variables including dissection and ﬂuid retention, andtherefore without performing additional analyses of ﬁber size and
number this cannot be conﬁrmed at the present time.
Decrements in mitochondrial function and biogenesis have com-
monly been associated with aging in skeletal muscle (Joseph et al.,
2012; Rooyackers et al., 1996; Short et al., 2005). The ability of caloric
restriction and resveratrol treatment to attenuate mitochondrial
deﬁcits and improve tissue function in various animal models is
thought to occur through an AMPK-Sirt1-PGC-1α-dependent path-
way (Baur et al., 2006; Canto et al., 2009; Dasgupta and Milbrandt,
2007; Egan et al., 2011; Lagouge et al., 2006; Price et al., 2012).
While the mechanistic details are unclear, it has recently been
Fig. 4. Protein levels of pro-apoptotic Bax and anti-apoptotic Bcl-2. Bax protein was measured via immunoblotting in white gastrocnemius (WG; A) and red gastrocnemius
(RG; C) muscles and Bcl-2 protein inWG (B) and RG (D). AL = ad-libitum, CR = caloric restricted, RSV = resveratrol, and CR + RSV = caloric restricted + resveratrol. Representative
Western blots, and the corresponding Ponceau S-stained membranes are shown above with a graphical summary of the data illustrated below (n = 4–11). Signiﬁcance was set at
P b 0.05 and all data are represented as mean ± SE. Data are expressed as arbitrary units (AU). *P b 0.05 vs. AL; †P b 0.05 vs. RSV group.
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lar levels of NAD+ and enhances Sirt1 activity, leading to the
deacetylation and activation of PGC-1α. Additionally, phosphoryla-
tion of PGC-1α by AMPK also promotes the deacetylation action of
Sirt1. Thus, PGC-1α can co-activate itself, to enhance its own tran-
scription, and positively regulate the expression of other nuclear
genes-encoding mitochondrial proteins to upregulate mitochondrial
biogenesis (Baur et al., 2006; Canto et al., 2009; Egan et al., 2011;
Lagouge et al., 2006; Nemoto et al., 2005; Price et al., 2012; Rodgers
et al., 2005; Suwa et al., 2003). In the present study, total PGC-1αprotein was increased with caloric restriction in white, glycolytic
gastrocnemius muscle ﬁbers but not in red, oxidative muscle ﬁbers.
Additionally, no changes were detected with caloric restriction in
AMPK activation or Sirt1 protein. While there is considerable evi-
dence pointing to a key role of AMPK and Sirt1 in promoting the ben-
eﬁcial effects of caloric restriction, several studies do not support this,
reporting no change in the activation of these factors following this
intervention (Gonzalez et al., 2004; To et al., 2007). Moreover, we
expected that the combination of caloric restriction and resveratrol
would produce an additive or even a synergistic effect on these
Fig. 5. Cell death in aged gastrocnemius muscle. DNA fragmentation was measured in
cytosol from WG (A) and RG (B) using a Cell death ELISA kit. The data are presented as
an apoptotic index. All data are represented as mean ± SE (n = 4–8).
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ﬁling comparing the speciﬁc intracellular effects of both caloric re-
striction and resveratrol in aging mice revealed a partial overlap
between the two treatments (Barger et al., 2008; Pearson et al.,
2008). Unexpectedly, our data suggest a blunted response of com-
bined caloric restriction and resveratrol treatment on PGC-1α pro-
tein, and at present we are unable to explain this except by
speculating that combined treatment regimens may potentially coun-
teract one another but further work is required to conﬁrm these
ﬁndings.
Previous studies have shown the efﬁcacy of resveratrol treatment to
protect against sarcopenia. Jackson et al. (2010) reported that low
doses of resveratrol (12.5 mg/kg/day for 21 days) attenuates muscle
loss following a more potent, short term muscle disuse model of
7 days of hind-limb suspension in aged 34 month old Fischer
344 × Brown Norway animals. Similar beneﬁts in muscle were also
observed when mice on a high-fat diet were supplemented with
slightly higher doses of resveratrol (22 mg/kg/day) (Baur et al.,
2006). However, in another study, 10 months of resveratrol treatment
(46 mg/kg/day) started at middle-age (18 months) was incapable
of attenuating the loss in muscle mass that occurred with aging
(Jackson et al., 2011).We found that resveratrol treatment induced sig-
niﬁcant changes in the longevity-related protein Sirt1 but that this was
not associated with improvements in muscle mass. Similar to our calo-
ric restriction results, changes in Sirt1 protein induced with resveratrol
did not coincide with detectable changes in AMPK or PGC-1α. Such in-
congruent ﬁndings in these regulatory proteins have previously been
reported following resveratrol treatment (Jackson et al., 2011; Um et
al., 2010). However, the activity of PGC-1α is tightly controlled by
post-translational modiﬁcations such as acetylation (Rodgers et al.,
2005). Unfortunately, we did not assess PGC-1α acetylation levels in
this study and are unable to conclude with certainty at the present
time whether PGC-1α activity is altered with these treatment
paradigms.
As mentioned above, there are variable accounts regarding the ben-
eﬁcial effects of resveratrol in skeletal muscle which have primarily
been attributed to differences in the dose and time of treatment. In
fact, recent dose and time course experiments with resveratrol clearly
indicate differential effects of moderate and high doses on intracellular
signaling pathways and downstream mitochondrial adaptations (Price
et al., 2012). Therefore, it appears that the efﬁcacy of resveratrol treat-
ment, at least in muscle, is largely dependent on the dose and time of
treatment, as well as the type of physiological perturbation being
investigated (i.e. aging, muscle disuse, high-fat diet). Inconsistent ﬁnd-
ings based on differences in dose and treatment times might also berelated to resveratrol's relatively poor bioavailability and rapid metab-
olism, which likely affects its protective functions (Das et al., 2008).
Additionally, it is currently unknown whether inherent differences
exist in the bioavailability of resveratrol in aged versus young
tissues or between oxidative and glycolytic ﬁbers. This may further
help to explain our modest effects in aged animals and some of the
ﬁber-type speciﬁc effects observed in our study. Thus, it is clear that a
more detailed characterization of the absorption and bioavailability of
resveratrol are needed in order to provide an accurate dosage for
resveratrol supplementation. Lastly, the lack of response in mitochon-
drial proteins observed in the more oxidative gastrocnemius muscle
points towards a ﬁber-speciﬁc action of these treatment regimens.
Although there is limited data investigating these differential ﬁber
type-speciﬁc effects, resveratrol treatment has been shown to cause a
shift towards more oxidative ﬁbers, and preferentially increases mito-
chondrial content and biogenesis in non-oxidative glycolytic ﬁbers
compared to oxidative ﬁbers (Lagouge et al., 2006; Price et al., 2012).
Collectively, we interpret these caloric restriction and resveratrol re-
sponses in muscle as being not only ﬁber type-speciﬁc but also likely
dependent on the dose and time of treatment.
It is well established that the apoptotic potential is higher in aged
muscle when compared to young muscle (Chabi et al., 2008; Dirks
and Leeuwenburgh, 2005) and that the efﬁcacy of both caloric restric-
tion and resveratrol to deter muscle loss, is largely due to higher levels
of endogenous antioxidants, as well as reduced mitochondrially-
mediated apoptotic susceptibility and cell death (Knutson and
Leeuwenburgh, 2008;Marzetti et al., 2009b). Resveratrol supplemen-
tation increased levels of the pro-apoptotic factor Bax, as well as the
anti-apoptotic protein Bcl-2 in white gastrocnemius muscle. We also
note that combined caloric restriction and resveratrol treatment atten-
uated the increase in Bax observed with resveratrol alone. Similar
inductions of Bcl-2 protein content with resveratrol have been con-
ﬁrmed by other studies (Brito et al., 2008; Jackson et al., 2010). Changes
in these pro- and anti-apoptotic proteins however, were not sufﬁcient
to alter the apoptotic potential of themuscle (Bax to Bcl-2 ratio). More-
over, the mitochondrial antioxidant enzyme, MnSOD was higher with
caloric restriction, which is consistent to previous reports (Qiu et al.,
2010). There is also evidence suggesting that MnSOD is upregulated
following resveratrol supplementation through a Sirt1-dependent
pathway (Tanno et al., 2010) but this was not observed in our study
or by others (Jackson et al., 2011).
We also observed differential apoptosis-related protein expression
patterns between muscle ﬁber-types following caloric restriction and
resveratrol treatment. Similar to other mitochondrial-associated pro-
teins discussed above, white gastrocnemius muscle was signiﬁcantly
more responsive than red gastrocnemius muscle. Type II glycolytic
ﬁbers are more susceptible than Type I oxidative ﬁbers to age-
associated decrements in mitochondrial function and apoptotic suscep-
tibility and this likely contributes to the greater loss of muscle mass
that is characteristic of these ﬁbers (Lexell, 1999; Muller et al., 2006;
Phillips and Leeuwenburgh, 2005). Therefore, it is certainly noteworthy
in our study that the muscle ﬁbers most susceptible to age-related
stress and damage (Type II glycolytic ﬁbers) are the most responsive
to our treatment paradigms (McKiernan et al., 2004). Moreover, the
fact that muscle mass changes and mitochondrial adaptations were
not associated with improvements in mitochondrial content or func-
tion may suggest the involvement of alternate mitochondrial quality
control processes. This is supported by recent evidence in human
cells that resveratrol activates autophagy cell death pathways through
a Sirt1-dependent mechanism, and that this is essential for the
lifespan-prolonging effects of resveratrol (Morselli et al., 2010). Inter-
estingly, under nutrient-limited conditions, AMPK activation can mod-
ulate autophagy through Sirt1, as well as by phosphorylating Ulk1, the
mammalian homolog of the yeast protein kinase Atg1 (Egan et al.,
2011; Kim et al., 2011; Lee et al., 2008, 2010). Finally, the importance
of autophagy in maintaining muscle quality control is supported with
867A.-M. Joseph et al. / Experimental Gerontology 48 (2013) 858–868the observation that mice lack the critical autophagy gene Atg7.
Muscle from these null animals exhibits a number of abnormalities
including mitochondrial dysfunction, myoﬁber degeneration, as well
as muscle atrophy and weakness (Masiero and Sandri, 2010). Whether
autophagy is required for the beneﬁcial effects of resveratrol and other
similar interventions in skeletal muscle is currently not known and will
be the focus of future studies.
5. Conclusions
The current data suggests that short-term moderate caloric
restriction (20%) and resveratrol (50 mg/kg/day) supplementation
initiated in late-life, modestly alter key mitochondrial biogenesis reg-
ulators and apoptotic signaling proteins in agedmuscle in a ﬁber-type
speciﬁc manner with glycolytic muscle being more responsive to
treatment than oxidative muscle. Furthermore, despite our original
hypothesis, combined moderate caloric restriction and resveratrol
treatment did not lead to any further additional beneﬁts as evidenced
by the lack of change in most proteins measured suggesting perhaps a
divergence in the molecular pathways through which these two reg-
imens act. It is clear from this study that further work in this area in-
vestigating the appropriate dose and time of resveratrol treatment in
older animals is warranted. Additionally, studies investigating the
effects of these treatments in different ﬁber types will be important
in understanding their speciﬁc modes of action in muscle and the
potential development of therapeutic treatments for sarcopenia.
6. Limitations of study
One limitation of the current study is that due to low tissue avail-
ability, we were unable to assess all mitochondrial markers in numer-
ous tissues exhibiting differential ﬁber type distributions. However,
we utilized tissues that provided a wide spectrum of ﬁber types
representing a high proportion of slow- and fast- twitch muscle
composition. Additionally, the absorption and bioavailability of res-
veratrol were not measured in each of the muscle ﬁber types investi-
gated. Thus, we are unable to draw conclusions on whether any of the
ﬁber type effects in this study are related to inherent differences
in the absorption and metabolism of resveratrol in different ﬁber
types. This possibility is being addressed in future studies.
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